RECRUITING

The COMPASSION Study

Description

The aim of this research study is to better understand the in-home hospice experience for participants, caregivers, hospice nurses, and oncology providers by conducting telehealth check-ins between participants and caregivers and oncology care teams.

Conditions

Breast CancerMetastatic Breast CancerAdvanced Breast CancerUnresectable Breast Carcinoma
Talk to us

Related Conditions:

Breast CancerMetastatic Breast CancerAdvanced Breast CancerUnresectable Breast Carcinoma

Study Overview

On this page

Study Details

Study overview

The aim of this research study is to better understand the in-home hospice experience for participants, caregivers, hospice nurses, and oncology providers by conducting telehealth check-ins between participants and caregivers and oncology care teams.

The COMPASSION Study: Applying Telehealth to Innovate and Strengthen Connections for Patients with Metastatic Breast Cancer Receiving Hospice Care

The COMPASSION Study

Condition
Breast Cancer
Intervention / Treatment

-

Contacts and Locations

Boston

Dana-Farber Cancer Institute, Boston, Massachusetts, United States, 02215

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Patient of any gender with unresectable locally advanced or metastatic breast cancer
  • * Eligible for in-home hospice services and referred by DFCI clinical team to in-home hospice \</= 1 week before enrollment
  • * Ability to conduct video or phone check-ins, even if assistance required.
  • * Able to provide verbal consent with a willingness to take a survey at 4-6 weeks, if medically able
  • * Hospice setting is within Massachusetts
  • * Non-English language allowed but interpreter services must be present at each meeting and will be coordinated by scheduling team
  • * Willingness to provide a caregiver/loved one's contact information for survey contact at 4 weeks after enrollment
  • * Unable to provide verbal consent
  • * Hospice care planned outside of a home setting (note: if participants start out in a home hospice setting but later transition their hospice care to an inpatient setting, enrollment is allowed as long as they started in a home setting)
  • * Hospice setting outside of Massachusetts
  • * Individuals who are under the age of 18, as this is not a project focused on pediatric patients.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Dana-Farber Cancer Institute,

Claire Smith, MD, PRINCIPAL_INVESTIGATOR, Dana-Farber Cancer Institute

Study Record Dates

2026-03-01